Dual Antiplatelet and Glycoprotein Inhibitors in Emergency PCI
Platelet inhibition remains the core pharmacotherapy component in patients under-going emergency or primary percutaneous coronary interventions (PCI). This can be achieved using a number of intravenous and oral preparations. Intravenous (iv) antiplatelets include various glycoprotein IIb/IIIa (...
Saved in:
Main Authors: | Ling, Hwei Sung, Alan, F.Y.Y. |
---|---|
Format: | Book Chapter |
Language: | English |
Published: |
Singapore Springer
2018
|
Subjects: | |
Online Access: | http://ir.unimas.my/id/eprint/34851/1/new1.pdf http://ir.unimas.my/id/eprint/34851/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Burden of nonsteroidal anti-inflammatory and antiplatelet drug use in Asia: a multidisciplinary working party report
by: Chan, F.K., et al.
Published: (2012) -
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial
by: Kedhi, Elvin, et al.
Published: (2021) -
Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial
by: Verdoia, Monica, et al.
Published: (2021) -
Determination Of Mitragynine As A Substrate, Inducer, Or Inhibitor Of P-Glycoprotein Drug Transporter, And Prediction Of Drug-Herb Interaction Risks
by: Rusli, Noradliyanti
Published: (2017) -
Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples
by: Meshkat, Z., et al.
Published: (2012)